Global Listeria monocytogenes Infections Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2016 to 2022

  • ID: 4313271
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Astra Zeneca plc
  • Eli Lilly and Company
  • Johnson & Johnson Limited
  • Medimmune
  • Merck & Co.
  • MORE
Global Listeria monocytogenes Infections Treatment Market - Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2016 - 2022, the Listeria monocytogenes infections treatment market was valued at USD 3,624.9 Mn in 2015, and is expected to reach USD 5,056.3 Mn by 2022, expanding at a CAGR of 4.74% from 2016 to 2022.

Market Insights
Listeria monocytogenes, is an important pathogen in pregnant patients, neonates, elderly individuals, and immunocompromised individuals, although an uncommon cause of illness in the general population. Listeria monocytogenes is a bacterial pathogen capable of causing severe infections in humans, often with fatal outcomes. According to USFDA, published studies suggest that 1- 8% of humans may be intestinal carriers of Listeria. According to Unites States Department of Agriculture (USDA), Listeria causes about 280 cases of illness in newborns in a typical year, resulting in 60 deaths and stillbirths. Infants can be infected before birth, and this infection can cause serious disability in newborns. About 35 infants are disabled as a result of infection from Listeria each year. The key factors assisting the growth of Listeria monocytogenes infections treatment market are rise in prevalence of foodborne diseases, stringent laws and policies issued by FDA, rising demand for healthy and microbial-free food, and high public awareness related to foodborne diseases in developed countries.

Pipeline Analysis
The phase III drugs included in the pipeline analysis are Carbavance (The Medicines Company), Telavancin (Theravance Biopharma Antibiotics, Inc.), Daptomycin (Merck & Co.), Prulifloxacin (Merck & Co.), and DTaP-IPV/Hib combined vaccine (Sanofi S.A.). According to market experts, the diversity of the several molecule types in the biologic group shows a certain level of innovation, with newer avenues being explored in accounts of recent failures. Overall, late stage clinical trials have highlighted very few molecules that could potentially replace current treatments during the forecast period.

Key Market Movements
  • Rising prevalence of foodborne infections in developed and developing countries
  • The incidence and prevalence of Listeria monocytogenes infections is high in pediatric and geriatric population
  • Stringent regulatory policies applied by FDA and other government agencies across the world is expected to reduce the risk of infection outbreak
  • Novel and developed treatments in pipeline are expected to assist the overall market growth of Listeria monocytogenes infections treatment market
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Astra Zeneca plc
  • Eli Lilly and Company
  • Johnson & Johnson Limited
  • Medimmune
  • Merck & Co.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 Usp and Key Offerings
1.2 Research Methodology

Chapter 2 Executive Summary
2.1 Global Listeria Monocytogenes Infections Treatment Market Portaiture
2.2 Global Listeria Monocytogenes Infections Treatment Treament Market, by Drugs, 2015 (USD Mn)
2.3 Relativity Analysis: Global Listeria Monocytogenes Infections Treatment Market, by Geography, 2015 & 2022 (USD Mn)

Chapter 3 Listeria Monocytogenes Infections Treatment Market: Market Dynamics and Outlook
3.1 Listeria Monocytogenes Infections Treatment Market Overview
3.2 Market Inclination Insights
3.3 Market Dynamics
3.3.1 Drivers
3.3.2 Challenges
3.3.3 Opportunities
3.4 Attractive Investment Proposition
3.5 Competitive Analysis
3.5.1 Market Share Analysis: Global Listeria Monocytogenes Infections Treatment Market, 2015 (Value %)

Chapter 4 Global Listeria Monocytogenes Infections Treatment Market, by Type of Infection
4.1 Preface
4.2 Bacteremia
4.3 Meningitis
4.4 Brain Abscess
4.5 Gastroenteritis
4.6 Endocarditis
4.7 Others
4.8 Pipeline Analysis
4.8.1 Projected Sales of Phase III Drugs Estimated Till 2022 (US$ Mn)
4.8.1.1 Carbavance
4.8.1.2 Telavancin
4.8.1.3 Daptomycin
4.8.1.4 Prulifloxacin
4.8.1.5 Dtap-Ipv/Hib Combined Vaccine
4.8.2 Tabular Representation of Phase II and I Drugs

Chapter 5 Global Listeria Monocyogenes Infections Treatment Market, by Geography
5.1 Preface
5.2 North America
5.2.1 U.S
5.2.2 Canada
5.3 Europe
5.3.1 U.K
5.3.2 Germany
5.3.3 Rest of Europe
5.4 Asia Pacific
5.4.1 China
5.4.2 Japan
5.4.3 Rest of Asia Pacific
5.5 Rest of the World (Row)
5.5.1 Latin America
5.5.2 Middle East and Africa

Chapter 6 Company Profiles
6.1 Pfizer Inc
6.1.1 Business Description
6.1.2 Financial Health and Budget Allocation
7.1.3 Product Portfolio
6.1.4 News Coverage
6.2 Novartis Ag
6.2.1 Business Description
6.2.2 Financial Health and Budget Allocation
6.2.3 Product Portfolio
6.2.4 News Coverage
6.3 Merck & Co
6.3.1 Business Description
6.3.2 Financial Health and Budget Allocation
6.3.3 Product Portfolio
V.3.4 News Coverage
6.4 Astra Zeneca Plc
6.4.1 Business Description
6.4.2 Financial Health and Budget Allocation
6.4.3 Product Portfolio
6.4.4 News Coverage
6.5 Johnson & Johnson Limited
6.5.1 Business Description
6.5.2 Financial Health and Budget Allocation
6.5.3 Product Portfolio
6.5.4 News Coverage
6.6 Abbott Laboratories
6.6.1 Business Description
6.6.2 Financial Health and Budget Allocation
6.6.3 Product Portfolio
6.6.4 News Coverage
6.7 Eli Lilly and Company
6.7.1 Business Description
6.7.2 Financial Health and Budget Allocation
6.7.3 Product Portfolio
6.7.4 News Coverage
6.8 Sanofi Sa
6.8.1 Business Description
6.8.2 Financial Health and Budget Allocation
6.8.3 Product Portfolio
6.8.4 News Coverage
6.9 Medimmune
6.9.1 Business Description
6.9.2 Financial Health and Budget Allocation
6.9.3 Product Portfolio
6.9.4 News Coverage
6.10 Baxter International, Inc
6.10.1 Business Description
6.10.2 Financial Health and Budget Allocation
6.10.3 Product Portfolio
6.10.4 News Coverage

List of Figures
Figure 1 Global Listeria Monocytogenes Infections Treatment Market, by Type of Infection, 2015 (USD Mn)
Figure 2 Relativity Analysis: Global Listeria Monocytogenes Infections Treatment Market, by Geography, 2015 & 2022 (USD Mn)
Figure 3 Attractive Investment Proposition, Global Listeria Monocytogenes Infections Treatment Market, 2015
Figure 4 Market Share Analysis: Global Listeria Monocytogenes Infections Treatment Market, 2015 (Value %)
Figure 5 Global Bacteremia Market of Listeria Monocytogenes Infections Treatment, 2013 - 2022 (USD Mn)
Figure 6 Global Meningitis Market of Listeria Monocytogenes Infections Treatment, 20137- 2022 (USD Mn)
Figure 7 Global Brain Abscess Market of Listeria Monocytogenes Infections Treatment, 2013 -2022 (USD Mn)
Figure 8 Global Gastroenteritis Market of Listeria Monocytogenes Infections Treatment, 2013 - 2022 (USD Mn)
Figure 9 Global Endocarditis Market of Listeria Monocytogenes Infections Treatment, 2013 - 2022 (USD Mn)
Figure 10 Global Others Market of Listeria Monocytogenes Infections Treatment, 2013 - 2022 (USD Mn)
Figure 11 Pipeline Analysis: Global Carbavance Market for Listeria Monocytogenes Infections Treatment, Upto 2022 (USD Mn)
Figure 12 Pipeline Analysis: Global Telavancin Market for Listeria Monocytogenes Infections Treatment, Upto 2022 (USD Mn)
Figure 13 Pipeline Analysis: Global Daptomycin Market for Listeria Monocytogenes Infections Treatment, Upto 2022 (USD Mn)
Figure 14 Pipeline Analysis: Global Prulifloxacin Market for Listeria Monocytogenes Infections Treatment, Upto 2022 (USD Mn)
Figure 15 Pipeline Analysis: Global Dtap-Ipv/Hib Combined Vaccine Market for Listeria Monocytogenes Infections, Upto 2022 (USD Mn)
Figure 16 Global U.S. Listeria Monocytogenes Infections Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 17 Global Canada Listeria Monocytogenes Infections Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 18 Global U.K Listeria Monocytogenes Infections Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 19 Global Germany Listeria Monocytogenes Infections Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 20 Global Rest of Europe Listeria Monocytogenes Infections Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 21 Global China Listeria Monocytogenes Infections Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 22 Global Japan Listeria Monocytogenes Infections Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 23 Global Rest of Asia Pacific Listeria Monocytogenes Infections Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 24 Global Latin America Listeria Monocytogenes Infections Treatment Market Revenue, 2013 - 2022 (USD Mn)
Figure 25 Global Middle East and Africa Listeria Monocytogenes Infections Treatment Market Revenue, 2013 - 2022 (USD Mn)

List of Tables
Table 1 Global Listeria Monocytogenes Infections Treatment Market Revenue, by Type of Infection, 2013 - 2022 (USD Mn)
Table 2 Global Listeria Monocytogenes Infections Treatment Market Revenue, by Geography, 2013 - 2022 (USD Mn)
Table 3 North America Listeria Monocytogenes Infections Treatment Market Revenue, by Country, 2013 - 2022 (USD Mn)
Table 4 Europe Listeria Monocytogenes Infections Treatment Market Revenue, by Country, 2013 - 2022 (USD Mn)
Table 5 Asia - Pacific Listeria Monocytogenes Infections Treatment Market Revenue, by Country, 2013 - 2022 (USD Mn)
Table 6 Rest of the World Listeria Monocytogenes Infections Treatment Market Revenue, by Region, 2013 - 2022 (USD Mn)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Pfizer Inc.
  • Novartis AG
  • Merck & Co.
  • Astra Zeneca plc
  • Johnson & Johnson Limited
  • Abbott Laboratories
  • Eli Lilly and Company
  • Sanofi SA
  • Medimmune
  • Baxter International, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll